USA Endoscopic Devices Market Outlook to 2028

USA Endoscopic Devices Market Overview

The USA endoscopic devices market is valued at USD 6 billion, driven by the rising demand for minimally invasive surgeries. This growth can be attributed to the increasing prevalence of chronic diseases, such as gastrointestinal disorders, colorectal cancer, and respiratory conditions, where endoscopy is a preferred diagnostic and therapeutic tool.

Dominant regions in the USA that drive this market include California and Texas, owing to their large population bases, the presence of advanced healthcare infrastructures, and a high concentration of specialized hospitals and clinics. These regions also have a high number of surgeries performed, driven by the availability of skilled professionals and early adoption of advanced medical technologies, which makes them market leaders in terms of revenue generation.

The FDAs Center for Devices and Radiological Health (CDRH) has prioritized the approval of innovative endoscopic devices through its Expedited Access Pathway (EAP) program. This has resulted in faster approvals for endoscopic devices aimed at treating critical conditions like colorectal cancer, with more than 25 new devices receiving approval between 2022 and 2024.

USA Endoscopic Devices Market Segmentation

By Device Type: The market is segmented by device type into rigid endoscopes, flexible endoscopes, capsule endoscopes, robot-assisted endoscopes, and disposable endoscopes. Among these, flexible endoscopes hold a dominant market share, primarily due to their versatility in performing various types of endoscopic procedures, such as gastrointestinal and pulmonary procedures. These devices are preferred by healthcare professionals for their ability to navigate through complex anatomical structures, providing a minimally invasive option for patients.

By Application: The market is also segmented by application into gastrointestinal endoscopy, pulmonary endoscopy, gynecological endoscopy, urological endoscopy, and ENT endoscopy. Gastrointestinal endoscopy is the largest sub-segment, dominating the market due to the high prevalence of gastrointestinal diseases such as colorectal cancer and irritable bowel syndrome (IBS). The increasing demand for colonoscopies and the role of endoscopic devices in early cancer detection have bolstered the growth of this segment.

USA Endoscopic Devices Market Competitive Landscape

The market is dominated by several key players, both local and global, who contribute to market growth through constant product innovations, partnerships, and strategic investments. The competitive landscape is largely consolidated, with leading companies such as Olympus Corporation, Boston Scientific, and Stryker Corporation taking a major share of the market.

Company Name

Established Year

Headquarters

Revenue

R&D Investment

Product Range

Strategic Partnerships

Market Share

Key Products

Olympus Corporation

1919

Tokyo, Japan

Boston Scientific Corporation

1979

Marlborough, USA

Stryker Corporation

1941

Kalamazoo, USA

Karl Storz SE & Co. KG

1945

Tuttlingen, Germany

Medtronic plc

1949

Dublin, Ireland

USA Endoscopic Devices Market Analysis

Market Growth Drivers

Increasing Prevalence of Gastrointestinal Disorders: According to the American Cancer Society, around 106,970 new cases of colon cancer and 46,050 cases of rectal cancer are estimated in 2024 in the USA. This surge in cases drives the demand for endoscopic devices, particularly colonoscopies and sigmoidoscopies, to detect early stages of gastrointestinal diseases, including cancer. With over 19 million colonoscopies performed annually in the U.S., the demand for high-quality, efficient devices has grown to cater to both diagnostic and therapeutic needs.

Rising Geriatric Population: The United States Census Bureau estimates that by 2024, more than 58 million people in the USA will be aged 65 and older. This age group is particularly prone to conditions requiring endoscopic interventions, such as colorectal cancer, peptic ulcers, and gastrointestinal bleeding. The aging population has led to an increased number of procedures, with over 4.5 million upper GI endoscopies performed annually, enhancing the demand for advanced endoscopic devices to ensure effective treatment and patient care.

Surge in Minimally Invasive Surgeries: In 2024, it is estimated that over 14.5 million minimally invasive surgeries will be performed in the USA, including a portion that utilizes endoscopic devices. Patients and healthcare providers increasingly prefer these procedures due to reduced recovery time and hospital stays. Endoscopic devices such as flexible endoscopes, camera systems, and energy devices are integral in procedures like laparoscopic surgeries, which account for over 3 million cases annually in the country.

Market Challenges

Rising Incidents of Dry Eye and Lens Discomfort: According to the National Eye Institute, dry eye syndrome affects over 16 million Americans, with a number of them reporting discomfort while wearing contact lenses. This has led to a 20% decline in the use of contact lenses among this population in recent years, prompting manufacturers to invest in developing more breathable and comfortable materials.

Lack of Insurance Coverage for Contact Lenses: In 2024, over 80 million Americans with vision correction needs had limited insurance coverage for contact lenses, according to the Centers for Medicare & Medicaid Services (CMS). Most insurance plans only cover eyeglasses, leaving a substantial out-of-pocket cost for contact lenses. This financial barrier has slowed the adoption of contact lenses in favor of glasses among price-sensitive consumers.

USA Endoscopic Devices Market Future Outlook

Over the next five years, the USA endoscopic devices industry is expected to exhibit growth, driven by the increasing demand for less invasive diagnostic procedures and advances in imaging technologies. The growing elderly population in the USA and the rise in chronic diseases such as colorectal cancer and digestive disorders will also fuel the market's growth.

Future Market Opportunities

Growing Demand for Multifocal Lenses in Aging Population: By 2029, the U.S. population over the age of 65 is expected to reach 60 million, further driving demand for multifocal contact lenses as presbyopia becomes more prevalent. This demographic shift will prompt manufacturers to develop more advanced lenses that cater specifically to the elderly, increasing the availability of lenses designed for prolonged wear and enhanced comfort.

Advancement in Smart Contact Lens Technology: The market for smart contact lenses is expected to grow exponentially over the next five years, with projections indicating over 1 million units in circulation by 2029. These lenses, featuring AR capabilities, glucose monitoring for diabetic patients, and real-time health data, will attract tech-savvy consumers and revolutionize the way contact lenses are used in everyday life.
Please Note: It will take 5-7 business days to complete the report upon order confirmation